Branded Generics: A Gateway to Emerging Markets

Date: June 22, 2010
Pages: 46
Price:
US$ 295.00
Publisher: FirstWord
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B10B8CA6CD9EN
Leaflet:

Download PDF Leaflet

Branded Generics: A Gateway to Emerging Markets
Around the globe, emerging markets are on the move. From Brazil, Russia and India to China, Turkey, Mexico and South Korea, experts predict emerging markets will represent 70 percent of industry growth rates by 2013.

While some leading companies have already established their foothold in those regions with the standard approach of offering low-volume innovative drugs to the emerging middle class, others are taking a far more inventive approach—branded generics.

A hybrid of generic and brand name products, branded generics not only allow companies to use existing distribution systems and established marketing techniques to sell premium-priced generics, they offer consumers the reassurance of a trusted name amidst rising fears of unsafe counterfeits.

What’s more, it makes sense. Along with a dense population constantly searching for a better standard of living, increased lifestyle-related disease and new healthcare reforms in developing nations, emerging markets offer untapped potential.

In Branded Generics--A Gateway to Emerging Markets , FirstWord delves into the potential of branded generics, and the progress key companies are already experiencing. The report, which explores the strategies being employed, from acquiring generic companies to marketing licensed products, examines the opportunities, drawbacks and potential hurdles of this inventive approach. Offering an overview of the generics market in emerging economies, the report includes an outline of opportunities, case studies and a prescription for how to succeed. Concisely written and backed by solid statistics, charts and diagrams, FirstWord's latest report offers a fast-track into what has become a critical new market.

The report offers insights into
  • How major pharma companies are using innovative strategies to engage a new market
  • Which critical issues face new players

The report
  • Examines the current state of generics in emerging markets
  • Reviews which companies are making inroads and how
  • Includes statistics, charts and market analysis for Asia, Central and Eastern Europe and Latin America
  • Reviews strategies used for entry, pricing and branding
  • Provides an overview on the hurdles and opportunities for those entering the market
EXECUTIVE SUMMARY

EMERGING MARKETS

Factors aiding industry growth in emerging markets
  Not realizing full potential

OVERVIEW OF THE GLOBAL GENERICS MARKET

Generic Market Growth factors
Generics Market Statistics
  Big Pharma Enters the Generics Market
  Branded Generics
    Branded Generics in Emerging Markets
    Strategies for Branded Generics in Emerging Markets
Big Pharma Enters the Generics Market

CENTRAL AND EASTERN EUROPE

Opportunities for Generics
Main Players in the Generics Market
Branded Generics
  Case Study: Polish Generics Market
Factors Aiding Success in CEE Markets

EMERGING MARKETS OF ASIA

China
  Generics in China
  International Presence in the Chinese Market
  Opportunities
  How to succeed
India
  Opportunities in the Indian Market
  The Indian Market for Generics
  Physician Perception of Branded Generics
  Keys for success

LATIN AMERICA

Generic Drugs in Latin America
Case Study: Brazil
How to succeed in Latin America

CONCLUSION

INDEX
Skip to top


Pharma Market Insights: Generics US$ 1,645.00 Sep, 2010 · 260 pages
Zydus Cadila Generics Company Intelligence Report US$ 340.00 Jan, 2011 · 12 pages
Booming Pharma Sector in India US$ 1,100.00 Apr, 2010 · 105 pages
Indian Pharma Sector Forecast 2014 US$ 800.00 May, 2011 · 105 pages

Ask Your Question

Branded Generics: A Gateway to Emerging Markets
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: